TrialJAMA2021

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.

Huiyan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.